Literature DB >> 31663122

Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.

Farzad Rahmani1, Aghigh Ziaeemehr2, Soodabeh Shahidsales3, Masoumeh Gharib4, Majid Khazaei5, Gordon A Ferns6, Mikhail Ryzhikov7, Amir Avan8,9, Seyed M Hassanian1,8.   

Abstract

Hepatocellular carcinoma (HCC) is one of the common malignant human tumors with high morbidity worldwide. Aberrant activation of the oncogenic phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling is related to clinicopathological features of HCC. Emerging data revealed that microRNAs (miRNAs) have prominent implications for regulating cellular proliferation, differentiation, apoptosis, and metabolism through targeting the PI3K/AKT/mTOR signaling axis. The recognition of the crucial role of miRNAs in hepatocarcinogenesis represents a promising area to identify novel anticancer therapeutics for HCC. The present study summarizes the major findings about the regulatory role of miRNAs in the PI3K/AKT/mTOR pathway in the pathogenesis of HCC.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  PI3K/AKT/mTOR pathway; hepatocellular carcinoma; microRNA

Mesh:

Substances:

Year:  2019        PMID: 31663122     DOI: 10.1002/jcp.29333

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  25 in total

1.  Network-Pharmacology-Based Study on Active Phytochemicals and Molecular Mechanism of Cnidium monnieri in Treating Hepatocellular Carcinoma.

Authors:  Shakeel Ahmad Khan; Terence Kin Wah Lee
Journal:  Int J Mol Sci       Date:  2022-05-12       Impact factor: 6.208

2.  Upregulation of miR-520c-3p via hepatitis B virus drives hepatocellular migration and invasion by the PTEN/AKT/NF-κB axis.

Authors:  Yang Liu; Jingwen Wang; Jianwen Chen; Shaoshuai Wu; Xianhuang Zeng; Qiushuang Xiong; Yandan Guo; Junwei Sun; Feifei Song; Jiaqi Xu; Sen Yuan; Chuang Li; Yuan He; Ming Wang; Lang Chen; Yun-Bo Shi; Mingxiong Guo; Deyin Guo; Guihong Sun
Journal:  Mol Ther Nucleic Acids       Date:  2022-05-20       Impact factor: 10.183

3.  PI3K/AKT/mTOR Pathway-Associated Genes Reveal a Putative Prognostic Signature Correlated with Immune Infiltration in Hepatocellular Carcinoma.

Authors:  Zhihuai Wang; Adeel Ur Rehman; Xihu Qin; Chunfu Zhu; Siyuan Wu
Journal:  Dis Markers       Date:  2022-05-09       Impact factor: 3.464

4.  CPA4 Promotes EMT in Pancreatic Cancer via Stimulating PI3K-AKT-mTOR Signaling.

Authors:  Qingliang Shao; Zhiqiang Zhang; Rongxian Cao; Hui Zang; Wanting Pei; Tian Sun
Journal:  Onco Targets Ther       Date:  2020-08-25       Impact factor: 4.147

5.  Overexpression of GINS4 Is Associated With Tumor Progression and Poor Survival in Hepatocellular Carcinoma.

Authors:  Ziying Zhang; Peng Chen; Hui Xie; Peiguo Cao
Journal:  Front Oncol       Date:  2021-03-25       Impact factor: 6.244

6.  MiR-491-5p, as a Tumor Suppressor, Prevents Migration and Invasion of Breast Cancer by Targeting ZNF-703 to Regulate AKT/mTOR Pathway.

Authors:  Jingyun Guo; Can Luo; Yuqin Yang; Jianyu Dong; Zhaoze Guo; Jinlamao Yang; Huining Lian; Changsheng Ye; Minfeng Liu
Journal:  Cancer Manag Res       Date:  2021-01-15       Impact factor: 3.989

Review 7.  Marine Anthraquinones: Pharmacological and Toxicological Issues.

Authors:  Giulia Greco; Eleonora Turrini; Elena Catanzaro; Carmela Fimognari
Journal:  Mar Drugs       Date:  2021-05-13       Impact factor: 5.118

8.  Downregulation of HBx Restrains Proliferation, Migration, and Invasion of HepG2 Cells.

Authors:  Chaoqun Huang; Wei Liu; Xiaochuan Zhao; Libin Zhao; Fuxiang Wang
Journal:  Anal Cell Pathol (Amst)       Date:  2021-05-13       Impact factor: 2.916

9.  VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy.

Authors:  Carolina Lavoz; Raul R Rodrigues-Diez; Anita Plaza; Daniel Carpio; Jesús Egido; Marta Ruiz-Ortega; Sergio Mezzano
Journal:  J Clin Med       Date:  2020-01-21       Impact factor: 4.241

Review 10.  PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers.

Authors:  Rui Liu; Youwen Chen; Guangzhi Liu; Chenxi Li; Yurong Song; Zhiwen Cao; Wen Li; Jinghong Hu; Cheng Lu; Yuanyan Liu
Journal:  Cell Death Dis       Date:  2020-09-24       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.